Cook County
Cook County was paid $5.10M by Medicaid between Jan 2018 and Feb 2024, across 238 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 26% of everything it billed.
CHICAGO, IL 60612
Next to other General Acute Care Hospital providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 171,906 | $1.39M | |
| 2019 | 299,442 | $2.90M | |
| 2020 | 99,314 | $805K | |
| 2023 | 83 | $281.50 | |
| 2024incomplete | 210 | $2K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 26% | 15,773 | 7,629 | $1.34M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 7.2% | 17,525 | 16,299 | $368K |
| J9035 | Injection, bevacizumab, 10 mg | 7.0% | 206 | 26 | $357K |
| 87536 | 5.3% | 7,699 | 7,035 | $271K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.7% | 2,983 | 2,887 | $188K |
| J9271 | Injection, pembrolizumab, 1 mg | 3.5% | 36 | 12 | $181K |
| 86480 | 3.0% | 4,114 | 3,854 | $155K | |
| 97161 | 2.9% | 3,096 | 1,747 | $150K | |
| 97162 | 2.1% | 1,890 | 1,082 | $106K | |
| 80053 | Comprehensive metabolic panel | 1.8% | 32,893 | 30,277 | $92K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.7% | 6,381 | 2,404 | $86K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 19,275 | 17,669 | $82K |
226 more codes
| 86631 | 1.3% | 17,028 | $66K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 26,904 | $60K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 5,220 | $53K |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 1,339 | $48K |
| 80306 | <1% | 8,539 | $47K | |
| 87522 | Neg quan hep c or qual rna | <1% | 1,956 | $46K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,411 | $46K |
| 86780 | <1% | 13,375 | $40K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 4,783 | $40K |
| 83655 | <1% | 4,337 | $40K | |
| 82652 | <1% | 6,458 | $37K | |
| Q5102 | Injection, infliximab, biosimilar, 10 mg | <1% | 31 | $37K |
| 77066 | Tomosynthesis, mammo | <1% | 478 | $37K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 31,461 | $36K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,324 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 36,132 | $34K |
| 92557 | <1% | 875 | $32K | |
| 96411 | <1% | 1,421 | $32K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,496 | $32K |
| 82274 | <1% | 5,437 | $27K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,923 | $23K |
| 96415 | <1% | 2,193 | $23K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,657 | $22K |
| 84439 | <1% | 11,605 | $22K | |
| 80061 | Lipid panel | <1% | 27,790 | $22K |
| 96417 | <1% | 1,747 | $21K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,107 | $21K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 188 | $21K |
| 90747 | <1% | 164 | $19K | |
| 77065 | Tomosynthesis, mammo | <1% | 330 | $19K |
| 90837 | Psychotherapy session, about an hour | <1% | 277 | $18K |
| 96920 | <1% | 275 | $18K | |
| 85027 | <1% | 20,075 | $18K | |
| 73610 | <1% | 1,282 | $17K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 389 | $17K |
| 88304 | <1% | 789 | $16K | |
| 86803 | <1% | 4,802 | $15K | |
| 80076 | <1% | 13,526 | $15K | |
| J9045 | Injection, carboplatin, 50 mg | <1% | 647 | $15K |
| 87631 | <1% | 286 | $14K | |
| 84403 | <1% | 651 | $14K | |
| 85610 | <1% | 10,346 | $14K | |
| 86141 | <1% | 2,451 | $14K | |
| J9263 | Injection, oxaliplatin, 0.5 mg | <1% | 733 | $13K |
| 84153 | <1% | 3,263 | $13K | |
| 87516 | <1% | 341 | $13K | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 1,334 | $13K |
| 86360 | <1% | 7,090 | $13K | |
| 83970 | <1% | 1,062 | $13K | |
| 92567 | <1% | 993 | $12K | |
| 90630 | <1% | 1,318 | $12K | |
| 83615 | <1% | 14,984 | $11K | |
| 91200 | <1% | 797 | $11K | |
| 90674 | <1% | 1,331 | $11K | |
| 96416 | <1% | 1,110 | $11K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 92 | $10K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 333 | $9K |
| 73630 | <1% | 957 | $9K | |
| 73562 | <1% | 919 | $8K | |
| J9267 | Injection, paclitaxel, 1 mg | <1% | 325 | $8K |
| 73030 | <1% | 843 | $8K | |
| 82948 | <1% | 10,276 | $8K | |
| 73502 | <1% | 482 | $7K | |
| 73130 | <1% | 842 | $7K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 93 | $7K |
| 84702 | <1% | 2,560 | $7K | |
| 87340 | <1% | 3,891 | $6K | |
| 73565 | <1% | 385 | $6K | |
| 73110 | <1% | 611 | $6K | |
| 96368 | <1% | 463 | $6K | |
| 78454 | <1% | 14 | $6K | |
| 82607 | <1% | 2,477 | $6K | |
| 97165 | <1% | 1,045 | $5K | |
| 81001 | <1% | 12,819 | $5K | |
| 86336 | <1% | 453 | $5K | |
| 73590 | <1% | 580 | $5K | |
| 88342 | <1% | 503 | $5K | |
| 86003 | <1% | 2,977 | $5K | |
| 83550 | <1% | 2,801 | $5K | |
| 86235 | <1% | 1,079 | $5K | |
| 72100 | <1% | 396 | $5K | |
| 82043 | <1% | 8,776 | $4K | |
| 82105 | <1% | 886 | $4K | |
| 82533 | <1% | 1,245 | $4K | |
| 73560 | <1% | 412 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 487 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,931 | $3K |
| 72040 | <1% | 329 | $3K | |
| 83735 | <1% | 3,053 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,117 | $3K |
| 74246 | <1% | 122 | $3K | |
| 82378 | <1% | 735 | $3K | |
| 85730 | <1% | 3,532 | $3K | |
| 92568 | <1% | 225 | $3K | |
| J9060 | Injection, cisplatin, powder or solution, 10 mg | <1% | 119 | $3K |
| 86705 | <1% | 1,498 | $3K | |
| 87449 | <1% | 381 | $3K | |
| 96152 | <1% | 46 | $3K | |
| 86592 | <1% | 1,733 | $3K | |
| 82728 | <1% | 2,519 | $3K | |
| 84550 | <1% | 3,823 | $3K | |
| 96409 | <1% | 61 | $2K | |
| 84165 | <1% | 662 | $2K | |
| 83020 | <1% | 1,422 | $2K | |
| 86403 | <1% | 2,382 | $2K | |
| 90732 | <1% | 62 | $2K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 211 | $2K |
| 73620 | <1% | 332 | $2K | |
| 83880 | <1% | 521 | $2K | |
| J9171 | Injection, docetaxel, 1 mg | <1% | 16 | $2K |
| 73120 | <1% | 359 | $2K | |
| 88312 | <1% | 421 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 243 | $2K |
| 87181 | <1% | 1,386 | $2K | |
| 97166 | <1% | 325 | $2K | |
| 73080 | <1% | 210 | $2K | |
| 86762 | <1% | 1,874 | $2K | |
| 87253 | <1% | 275 | $2K | |
| 83883 | <1% | 237 | $2K | |
| 85651 | <1% | 2,545 | $2K | |
| 86316 | <1% | 472 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 172 | $2K |
| 84460 | <1% | 2,725 | $2K | |
| 86334 | <1% | 131 | $2K | |
| 82746 | <1% | 1,078 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 120 | $2K |
| 81025 | <1% | 2,010 | $2K | |
| 84154 | <1% | 166 | $2K | |
| 87081 | <1% | 1,097 | $1K | |
| 86361 | <1% | 396 | $1K | |
| 73552 | <1% | 148 | $1K | |
| 87070 | <1% | 701 | $1K | |
| 84450 | <1% | 2,666 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 429 | $1K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 375 | $1K |
| 84270 | <1% | 298 | $1K | |
| 82677 | <1% | 445 | $1K | |
| 84481 | <1% | 501 | $1K | |
| 82570 | <1% | 1,275 | $1K | |
| 86256 | <1% | 176 | $1K | |
| 86161 | <1% | 371 | $1K | |
| 73522 | <1% | 60 | $1K | |
| 86850 | <1% | 933 | $1K | |
| 82947 | <1% | 1,323 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 138 | $1K |
| 84100 | <1% | 1,725 | $998.72 | |
| 86787 | <1% | 198 | $979.80 | |
| 96900 | <1% | 157 | $905.40 | |
| 86735 | <1% | 212 | $860.21 | |
| 82088 | <1% | 30 | $855.13 | |
| 85009 | <1% | 3,781 | $845.22 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 236 | $843.38 |
| 82565 | <1% | 1,088 | $842.49 | |
| 83516 | <1% | 70 | $832.11 | |
| 84156 | <1% | 2,313 | $713.53 | |
| 82785 | <1% | 358 | $703.40 | |
| 82465 | <1% | 1,918 | $665.07 | |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | <1% | 37 | $662.57 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 227 | $638.69 |
| 86430 | <1% | 693 | $632.28 | |
| 86901 | <1% | 934 | $591.74 | |
| 90715 | <1% | 54 | $542.85 | |
| 87625 | <1% | 57 | $531.67 | |
| 82390 | <1% | 103 | $505.59 | |
| 88313 | <1% | 251 | $490.78 | |
| 86765 | <1% | 290 | $484.90 | |
| 84146 | <1% | 156 | $478.67 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 45 | $475.55 |
| 80047 | <1% | 126 | $460.85 | |
| 82550 | <1% | 478 | $460.33 | |
| 86039 | <1% | 203 | $442.61 | |
| 72110 | <1% | 27 | $426.16 | |
| 81003 | <1% | 736 | $418.92 | |
| 73060 | <1% | 65 | $417.60 | |
| 82670 | <1% | 182 | $414.88 | |
| 86900 | <1% | 933 | $402.00 | |
| 87205 | <1% | 637 | $401.11 | |
| 81002 | <1% | 643 | $387.49 | |
| 88173 | <1% | 27 | $368.50 | |
| 85018 | <1% | 1,101 | $362.54 | |
| 83921 | <1% | 35 | $339.55 | |
| 82040 | <1% | 452 | $314.53 | |
| 84520 | <1% | 730 | $313.90 | |
| 87510 | <1% | 21 | $305.88 | |
| 87480 | <1% | 21 | $305.88 | |
| 84445 | <1% | 12 | $289.26 | |
| 90686 | <1% | 47 | $280.52 | |
| 82951 | <1% | 49 | $260.35 | |
| 85014 | <1% | 634 | $250.62 | |
| 83690 | <1% | 215 | $220.26 | |
| 87341 | <1% | 95 | $205.65 | |
| 73090 | <1% | 26 | $188.65 | |
| 72170 | <1% | 30 | $185.46 | |
| 87660 | <1% | 21 | $180.86 | |
| 84244 | <1% | 27 | $167.52 | |
| 87324 | <1% | 31 | $160.65 | |
| 84480 | <1% | 108 | $159.12 | |
| 86255 | <1% | 41 | $133.53 | |
| 92134 | <1% | 15 | $131.94 | |
| 74018 | <1% | 13 | $130.96 | |
| 85045 | <1% | 454 | $130.66 | |
| 82247 | <1% | 61 | $124.94 | |
| 86702 | <1% | 57 | $119.88 | |
| 85660 | <1% | 114 | $100.18 | |
| 82103 | <1% | 28 | $95.06 | |
| 83013 | <1% | 19 | $67.64 | |
| 87046 | <1% | 87 | $57.54 | |
| 82150 | <1% | 52 | $55.89 | |
| 82955 | <1% | 13 | $50.34 | |
| 86709 | <1% | 132 | $40.57 | |
| 80185 | <1% | 12 | $38.04 | |
| 83037 | <1% | 102 | $36.02 | |
| 82248 | <1% | 36 | $28.40 | |
| 82310 | <1% | 14 | $18.12 | |
| 83525 | <1% | 26 | $17.36 | |
| 84300 | <1% | 15 | $16.50 | |
| 85384 | <1% | 14 | $10.31 | |
| 86021 | <1% | 14 | $6.12 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 92 | $2.45 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 77 | $0.99 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 29 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 16 | $0.00 |
| 80050 | General health panel | 0% | 13 | $0.00 |
| 80361 | 0% | 731 | $0.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 311 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| 2ND Chance Mental Health Center, LLC | Port St Lucie, FL | $630K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.